Do you need to hold Eliquis (apixaban) before cataract surgery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Eliquis Management for Cataract Surgery

You do not need to hold Eliquis (apixaban) before cataract surgery. Cataract surgery is classified as a low-bleeding-risk procedure, and observational evidence demonstrates no bleeding events when DOACs are continued through cataract surgery. 1

Evidence Supporting Continuation

  • A 25-patient observational study specifically assessed DOAC continuation in patients undergoing cataract surgery and identified zero bleeding events. 1

  • Cataract surgery (phacoemulsification) is described as a "largely avascular procedure" with an extremely low bleeding risk profile. 1

  • The American College of Chest Physicians 2022 guidelines classify cataract surgery among minor ophthalmologic procedures where anticoagulation continuation is safe. 1

Comparison to Warfarin Data

  • For warfarin (VKA) therapy, the 2022 CHEST guidelines explicitly recommend continuation around cataract surgery rather than interruption. 1

  • Meta-analyses of warfarin continuation during cataract surgery showed bleeding rates of approximately 10%, but almost all bleeds were self-limiting (dot hyphemas or subconjunctival hemorrhages) with no patient experiencing compromised visual acuity. 1

  • The 2012 CHEST guidelines similarly recommended continuing VKAs during cataract surgery. 1

Anesthesia Considerations

The critical caveat is anesthesia technique:

  • Topical or sub-Tenon's anesthesia is strongly preferred and carries minimal bleeding risk even with full anticoagulation. 1

  • Retrobulbar (intraconal) anesthesia poses significant concern due to the potential for retrobulbar hematoma, which can cause vision loss. 1

  • If retrobulbar anesthesia is planned, consider holding Eliquis for 1 day (24 hours) before the procedure, as this is the recommended duration for low-to-moderate bleeding risk procedures. 1, 2

Practical Algorithm

For standard cataract surgery with topical/sub-Tenon's anesthesia:

  • Continue Eliquis without interruption 1
  • No bridging anticoagulation needed 1, 2

For cataract surgery requiring retrobulbar anesthesia:

  • Hold Eliquis for 1 day (skip the dose the day before surgery) 1, 2
  • Resume 6-24 hours postoperatively once hemostasis confirmed 2, 3

For complex retinal surgery or higher-risk ophthalmologic procedures:

  • Hold Eliquis for 1 day before the procedure 1, 2
  • This applies to procedures beyond simple cataract extraction 1

Common Pitfalls to Avoid

  • Do not routinely hold Eliquis for standard cataract surgery – the evidence shows this is unnecessary and exposes patients to thromboembolic risk. 1

  • Do not use bridging anticoagulation – this increases bleeding risk without reducing thrombotic events. 1, 2

  • Do not ignore anesthesia technique – retrobulbar blocks carry higher bleeding risk than topical/sub-Tenon's approaches. 1

  • Do not assume all eye surgeries are equal – more complex retinal procedures may warrant brief interruption even though simple cataract surgery does not. 1

Supporting Research Evidence

  • A systematic review of 65,196 patients found that aspirin continuation increased only subconjunctival hemorrhage risk, with no increase in sight-threatening complications like hyphema, retrobulbar hemorrhage, or vitreous hemorrhage. 4

  • A prospective cohort of 19,283 cataract surgeries showed that continuation of anticoagulants resulted in extremely low rates of serious complications, with minimal absolute risk differences. 5

  • Multiple studies confirm that discontinuing anticoagulation before cataract surgery may increase thromboembolic risk without meaningful reduction in bleeding complications. 6, 7, 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Perioperative Management of Apixaban

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Anticoagulants and antiplatelet drugs during cataract surgery.

Arquivos brasileiros de oftalmologia, 2018

Research

Cataract surgery and anticoagulants.

Documenta ophthalmologica. Advances in ophthalmology, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.